Atlas Trials

Phase II Trial of Zanzalitinib in Patients With Metastatic Castration Resistant Prostate Cancer

Clinical trial NCT07608718 · NOT_YET_RECRUITING

Trial details

NCT number
NCT07608718
Sponsor
Pedro Barata, MD, MSc
Status
NOT_YET_RECRUITING
Phase
Phase 2
Study type
INTERVENTIONAL
Metastatic Castration-resistant Prostate Cancer
Start date
2026-09-01
Primary completion
2029-05-01
Enrollment
19

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.